Patient and Provider Characteristics Associated With Sodium-Glucose Cotransporter 2 Inhibitor Prescription in Patients With Diabetes and Proteinuric Chronic Kidney Disease.

McCoy, Ian E; Han, Jialin; Montez-Rath, Maria E; Chertow, Glenn M; Rhee, Jinnie J

McCoy, Ian E; Han, Jialin; Montez-Rath, Maria E; Chertow, Glenn M; Rhee, Jinnie J.

Afiliación

McCoy IE; Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA.
Han J; Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA.
Montez-Rath ME; Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA.
Chertow GM; Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA.
Rhee JJ; Stanford Diabetes Research Center, Stanford University School of Medicine, Palo Alto, CA.

Clin Diabetes ; 38(3): 240-247, 2020 Jul.

Article en En | MEDLINE | ID: mdl-32699472

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Clin Diabetes Año: 2020 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google